Clinical trial
A Randomized, Double-Blind, Placebo- Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
NCT04693351 is registered in ClinicalTrials.gov with Biohaven Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo- Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 29, 2021
- Completion date
- April 29, 2025
- Enrollment
- 589 (actual)
- Sites
- 89
Conditions
As the registry lists them; a condition with its own page is linked.